GSK secures rights to Syndivia’s ADC asset for prostate cancer
GSK Secures Rights to Syndivia's ADC Asset for Prostate Cancer GSK acquires exclusive rights from Syndivia for an ADC targeting advanced prostate cancer in a deal up to £268 million.
Cygnet Energy Enters into Agreement to Acquire Kiwetinohk Energy Corp.
Cygnet Energy Enters into Agreement to Acquire Kiwetinohk Energy Corp. Cygnet Energy Ltd., a private exploration and production com…
TCT 2025: TRILUMINATE Pivotal Trial Confirms Safety, Efficacy and Quality-of-Life (QoL) Gains with TriClip Transcatheter Edge-to-Edge Repair (T- TEER) for Tricuspid Regurgitation (TR)
TCT 2025: TRILUMINATE Pivotal Trial Results The Medical Dialogues Bureau at the TCT Conference 2025 in San Francisco, USA, reports on the …
Grokipedia launches after brief crash, accused of copying Wikipedia content - Tech Digest
Grokipedia Launch and Controversy Elon Musk's Grokipedia, a rival to Wikipedia, launched after a brief crash, sparking controversy over it…
Motsoaledi relaunches Parliamentary TB caucus to strengthen accountability, innovation
Motsoaledi Relaunches Parliamentary TB Caucus Health Minister Aaron Motsoaledi announced that the country is entering a new era of account…
SELUTION DeNovo Trial Demonstrates Non-Inferiority of Drug-Eluting Balloon to Standard-of-Care for In-Stent Restenosis: Late-Breaking Results from TCT 2025
SELUTION DeNovo Trial Results The SELUTION DeNovo randomized clinical trial, presented at TCT 2025 in San Francisco, USA, demonstrated non…
TCT 2025: ShortCUT Trial Compares Cutting Balloon Angioplasty and Intravascular Lithotripsy (IVL) for Calcified Coronary Artery Disease
TCT 2025: ShortCUT Trial Compares Cutting Balloon Angioplasty and Intravascular Lithotripsy (IVL) for Calcified Coronary Artery Disease Th…
EVOQUE Transcatheter Tricuspid Valve Replacement (TTVR) Demonstrates Favorable Real-World Outcomes: Early U.S. Experience Confirms Safety, Effectiveness, and Quality-of-Life Gains
EVOQUE Transcatheter Tricuspid Valve Replacement Demonstrates Favorable Outcomes The EVOQUE system has shown promising results in real-wor…